Clinical trial sites have been embracing and implementing remote technologies rapidly, with electronic consent (eConsent) applications seeing the fastest growth in the past six months, a recent survey shows.

More than half (57 percent) of 163 sites surveyed by software solutions developer Florence in July said they already have established eConsent systems and 18 percent said they are planning to implement it in the future. In a previous survey in December 2020, 47 percent of sites expressed interest in using eConsent.

Electronic medical records continue to be the most-used technology, with 78 percent of sites using them, followed by clinical trial management systems at 70 percent.

The July survey also found that 65 percent of sites use a telehealth application, with 10 percent planning to implement one, and 63 percent of sites have an electronic regulatory (eRegulatory) system in place, with 18 percent of sites expecting to adopt eRegulatory technology in the future.

Electronic source (eSource) applications were less popular; 43 percent of sites said they use eSource technology, an increase from the 37 percent reported in December, and 20 percent of sites said they may incorporate it in the future.

With 33 percent of respondents, recruitment software was the least-used solution, although 18 percent said they were considering using it in the future.

Read the full report here: https://bit.ly/38iBqnz.